1.Effect and Safety of Phytosomal Curcumin Supplementation on Migraine Patients: A Randomized, Double-Blind and Placebo-Controlled Trial.
Mehrnaz SHOJAEI ; Fariborz KHORVASH ; Amirhossein SAHEBKAR ; Thozhukat SATHYAPALAN ; Mohammad BAGHERNIYA
Chinese journal of integrative medicine 2025;31(11):963-972
OBJECTIVE:
To investigate the effect and safety of phytosomal curcumin supplementation on patients with migraine.
METHODS:
In this randomized, double-blind and placebo-controlled trial, 70 patients suffered from migraine without aura were randomized into 2 groups to receive 250 mg/d of phytosomal curcumin (intervention group) or maltodextrin (placebo group) for 8 weeks, 35 cases per group. All patients in both groups received their standard treatment and common medications. The severity, duration, frequency of headaches, quality of life (QoL), mental status, headache impact, and sleep quality of patients were assessed before and after treatment. Adverse effects were also assessed.
RESULTS:
Sixty-five patients completed the trial (33 in the intervention group and 32 in the placebo group). Phytosomal curcumin supplementation significantly reduced severity, duration and frequency of migraine attacks, stress score, and headache impact, and improved QoL and sleep quality of patients in the intervention group, compared with the placebo group (P<0.05 or P<0.01). However, it had no significant effect on depression and anxiety scores in the intervention group, compared with the placebo group (P>0.05). No adverse effects had been reported in response to the intervention.
CONCLUSION
Phytosomal curcumin as a safe supplement had a beneficial effect on migraine symptoms, stress level, as well as the sleep quality and QoL in patients with migraine. (Trial registration No. IRCT20201129049534N2).
Humans
;
Curcumin/adverse effects*
;
Double-Blind Method
;
Male
;
Female
;
Dietary Supplements/adverse effects*
;
Migraine Disorders/drug therapy*
;
Adult
;
Quality of Life
;
Middle Aged
;
Placebos
;
Treatment Outcome
2.Pre-pregnancy Body Mass Index and Maternal Nutrition in Relation to Infant Birth Size
Shabbou Ahmadi BONAKDAR ; Ahmad Reza DOROSTY MOTLAGH ; Mohammad BAGHERNIYA ; Golnaz RANJBAR ; Reza DARYABEYGI-KHOTBEHSARA ; Seyed Amir Reza MOHAJERI ; Mohammad SAFARIAN
Clinical Nutrition Research 2019;8(2):129-137
This cross-sectional study examined the relationship between maternal pre-pregnancy body mass index (BMI) and dietary intake on birth size in the north-east part of Iran. Maternal information including BMI and dietary intake from 453 healthy pregnant women were collected in 2013–2014. Maternal pre-pregnancy BMI were obtained from health records and dietary intakes in third trimester were collected by using a validated food frequency questionnaire (FFQ), which consisted of 160 Iranian foods. Anthropometric measurements of neonates including weight, height, and head circumference were 3.19 ± 0.49 kg, 50.24 ± 2.1 cm, and 34.61 ± 1.5 cm, respectively. A significant difference was found in neonatal birth weight (p < 0.001) and head circumference (p = 0.002) between underweight and obese mothers. Furthermore, maternal intake of fat had a direct correlation with birth size. There was a positive relationship between vitamin A and potassium intake and birth height. The article concludes that normal maternal pre-pregnancy weight and appropriate diet are likely essential for healthy babies.
Birth Weight
;
Body Mass Index
;
Cross-Sectional Studies
;
Diet
;
Female
;
Head
;
Humans
;
Infant
;
Infant, Newborn
;
Iran
;
Mothers
;
Parturition
;
Potassium
;
Pregnancy
;
Pregnancy Trimester, Third
;
Pregnant Women
;
Thinness
;
Vitamin A

Result Analysis
Print
Save
E-mail